Renaissance Technologies
MR

Renaissance Technologies’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

Renaissance Technologies’s Portfolio MR Stock Details MR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-1,705,100
Closed -$46.2M – 3681
2015
Q4 		$46.2M Buy
1,705,100
+963,700
+130% +$24.8M 0.1% 228
2015
Q3 		$16.2M Buy
741,400
+199,500
+37% +$5.09M 0.04% 611
2015
Q2 		$15.4M Buy
541,900
+30,100
+6% +$877K 0.04% 684
2015
Q1 		$14M Sell
511,800
-415,500
-45% -$11.4M 0.03% 761
2014
Q4 		$24.5M Buy
927,300
+653,200
+238% +$19.1M 0.06% 404
2014
Q3 		$8.27M Sell
274,100
-126,400
-32% -$3.91M 0.02% 879
2014
Q2 		$12.6M Buy
400,500
+188,350
+89% +$5.98M 0.03% 712
2014
Q1 		$6.87M Buy
+212,150
New +$7.43M 0.02% 1081
2013
Q4 		– Sell
-358,000
Closed -$13.9M – 3158
2013
Q3 		$13.9M Buy
358,000
+99,200
+38% +$4M 0.03% 632
2013
Q2 		$9.69M Buy
+258,800
New +$10.2M 0.03% 754

Other funds holding MR

Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Renaissance Technologies's MR Position: Q1 2016 in Review

Renaissance Technologies sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q1 2016, closing a stake of 1,705,100 shares — an estimated $46.2M sold.

Renaissance Technologies first reported a position in MR in Q2 2013 and held it in 10 quarters. The position peaked at $46.2M in Q4 2015. 2 funds tracked by Wall St. Rank hold MR as of Q1 2016.

  • Renaissance Technologies reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q1 2016 after selling out during the quarter.
  • Renaissance Technologies sold 1,705,100 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q1 2016, an estimated $46.2M.
  • Renaissance Technologies first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q2 2013 and held it in 10 quarters.
  • Renaissance Technologies's MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $46.2M in Q4 2015.
  • 2 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q1 2016.

Based on Renaissance Technologies's 13F filing for Q1 2016, filed 13 May 2016.